358 related articles for article (PubMed ID: 12094882)
1. Botulinum toxin for the treatment of gastroparesis: a preliminary report.
Lacy BE; Zayat EN; Crowell MD; Schuster MM
Am J Gastroenterol; 2002 Jun; 97(6):1548-52. PubMed ID: 12094882
[TBL] [Abstract][Full Text] [Related]
2. Treatment of idiopathic gastroparesis with injection of botulinum toxin into the pyloric sphincter muscle.
Miller LS; Szych GA; Kantor SB; Bromer MQ; Knight LC; Maurer AH; Fisher RS; Parkman HP
Am J Gastroenterol; 2002 Jul; 97(7):1653-60. PubMed ID: 12135014
[TBL] [Abstract][Full Text] [Related]
3. Influence of intrapyloric botulinum toxin injection on gastric emptying and meal-related symptoms in gastroparesis patients.
Arts J; van Gool S; Caenepeel P; Verbeke K; Janssens J; Tack J
Aliment Pharmacol Ther; 2006 Aug; 24(4):661-7. PubMed ID: 16907899
[TBL] [Abstract][Full Text] [Related]
4. Clinical trial: a randomized-controlled crossover study of intrapyloric injection of botulinum toxin in gastroparesis.
Arts J; Holvoet L; Caenepeel P; Bisschops R; Sifrim D; Verbeke K; Janssens J; Tack J
Aliment Pharmacol Ther; 2007 Nov; 26(9):1251-8. PubMed ID: 17944739
[TBL] [Abstract][Full Text] [Related]
5. [Gastroparesis--diagnosis and treatment].
Ciortescu I; Stanciu C
Rev Med Chir Soc Med Nat Iasi; 2009; 113(2):330-8. PubMed ID: 21495337
[TBL] [Abstract][Full Text] [Related]
6. Review article: The diagnosis and management of gastroparesis.
Haans JJ; Masclee AA
Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():37-46. PubMed ID: 18081647
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin A for the treatment of delayed gastric emptying.
Friedenberg FK; Palit A; Parkman HP; Hanlon A; Nelson DB
Am J Gastroenterol; 2008 Feb; 103(2):416-23. PubMed ID: 18070232
[TBL] [Abstract][Full Text] [Related]
8. A systematic review on intrapyloric botulinum toxin injection for gastroparesis.
Bai Y; Xu MJ; Yang X; Xu C; Gao J; Zou DW; Li ZS
Digestion; 2010; 81(1):27-34. PubMed ID: 20029206
[TBL] [Abstract][Full Text] [Related]
9. Gastric electrical stimulation: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(16):1-79. PubMed ID: 23074486
[TBL] [Abstract][Full Text] [Related]
10. Use of metoclopramide, domperidone, and cisapride in the management of diabetic gastroparesis.
Brown CK; Khanderia U
Clin Pharm; 1990 May; 9(5):357-65. PubMed ID: 2190745
[TBL] [Abstract][Full Text] [Related]
11. The treatment of diabetic gastroparesis with botulinum toxin injection of the pylorus.
Lacy BE; Crowell MD; Schettler-Duncan A; Mathis C; Pasricha PJ
Diabetes Care; 2004 Oct; 27(10):2341-7. PubMed ID: 15451898
[TBL] [Abstract][Full Text] [Related]
12. Gastroparesis: approach, diagnostic evaluation, and management.
Tang DM; Friedenberg FK
Dis Mon; 2011 Feb; 57(2):74-101. PubMed ID: 21329779
[TBL] [Abstract][Full Text] [Related]
13. Gastroparesis and the current use of prokinetic drugs.
Kendall BJ; McCallum RW
Gastroenterologist; 1993 Jun; 1(2):107-14. PubMed ID: 8049884
[TBL] [Abstract][Full Text] [Related]
14. A preliminary report of the use of botulinum toxin type A in infants with clubfoot: four case studies.
Delgado MR; Wilson H; Johnston C; Richards S; Karol L
J Pediatr Orthop; 2000; 20(4):533-8. PubMed ID: 10912614
[TBL] [Abstract][Full Text] [Related]
15. Management of diabetic gastroparesis.
Mukhopadhyay P; Basu AK
J Indian Med Assoc; 2005 Mar; 103(3):184, 186. PubMed ID: 16173296
[TBL] [Abstract][Full Text] [Related]
16. Treatment of gastroparesis: an update.
Gumaste V; Baum J
Digestion; 2008; 78(4):173-9. PubMed ID: 19092243
[TBL] [Abstract][Full Text] [Related]
17. Treatment of refractory gastroparesis: gastric and jejunal tubes, botox, gastric electrical stimulation, and surgery.
Hejazi RA; McCallum RW
Gastrointest Endosc Clin N Am; 2009 Jan; 19(1):73-82, vi. PubMed ID: 19232282
[TBL] [Abstract][Full Text] [Related]
18. Mirtazapine for severe gastroparesis unresponsive to conventional prokinetic treatment.
Kim SW; Shin IS; Kim JM; Kang HC; Mun JU; Yang SJ; Yoon JS
Psychosomatics; 2006; 47(5):440-2. PubMed ID: 16959934
[TBL] [Abstract][Full Text] [Related]
19. Long-term results and prognostic factors in the treatment of achalasia with botulinum toxin.
Neubrand M; Scheurlen C; Schepke M; Sauerbruch T
Endoscopy; 2002 Jul; 34(7):519-23. PubMed ID: 12170400
[TBL] [Abstract][Full Text] [Related]
20. A prospective study of botulinum toxin for internal anal sphincter hypertonicity in children with Hirschsprung's disease.
Minkes RK; Langer JC
J Pediatr Surg; 2000 Dec; 35(12):1733-6. PubMed ID: 11101725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
